The World’s Health Care Crisis: Geopolitical and Climate Change Challenges focuses on the global health care crisis, providing information on new challenges the world is experiencing, such as COVID-19, massive world migration, overpopulation, threats of global famine, nuclear war, the emergence of new infectious diseases around the planet, climate change, and their effects on health care. The book's target audience includes professionals of health systems, biomedical innovation, and global health supply chains investors and Directors in Chief, decision-makers in public health, multilateral…mehr
The World’s Health Care Crisis: Geopolitical and Climate Change Challenges focuses on the global health care crisis, providing information on new challenges the world is experiencing, such as COVID-19, massive world migration, overpopulation, threats of global famine, nuclear war, the emergence of new infectious diseases around the planet, climate change, and their effects on health care. The book's target audience includes professionals of health systems, biomedical innovation, and global health supply chains investors and Directors in Chief, decision-makers in public health, multilateral institutions in regulatory, legislative, and executive areas, researchers, health sciences students, health economists, economist associations, pharmaco-economists, historians, and more.
Ibis Sánchez-Serrano is a world-leading expert on global healthcare, pharmaceutical innovation, and translational science policy. He is a member of the Editorial Board of the journal Gender & the Genome and has written two books, The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside (Elsevier, 2011) and The Core Model: A Collaborative Paradigm for the Pharmaceutical Industry and Global Health Care (Elsevier, 2019). Mr. Sánchez-Serrano has built a reputation amongst important international government bodies as an expert on the world's healthcare crisis and the relevant solutions. He's a frequent speaker on global health care and pharmaceutical development and received international recognitions for his work on global health care, including a "Fulbright Recognition Award? and media coverage including CNN, C-SPAN, UNIVISION, EFE Agency, Deutsche Presse Agentur. His research interests include Health Care, Pharmaceuticals, Biotechnology, Public Health, Academia-Industry Relationship, Drug Discovery and Development, Organization and Management of R&D.
Inhaltsangabe
PART I: The World’s Health Care Crisis 1. Introduction: Health Care and Health Care Crisis 2. The Health Care Crisis in the Industrialized World 3. Health Care in the Developing World and Emergent Economies PART II: The Biopharmaceutical Industry and Its Challenges 4. The Pharmaceutical Industry Globally 5. Understanding Research and Development and Marketing in a Biopharmaceutical Company 6. The Pharmaceutical Regulators and the Process of Drug Approval PART III: Life Sciences and Pharmaceutical Innovation 7. The Academia-Industry Relationship 8. Innovation at the Pharmaceutical and Biotechnology Industries 9. Global Investments in Life Sciences and Pharmaceutical Innovation PART IV: A World of Inequalities 10. Global health care disparities 11. Social Responsibility, Governmental Role, and Non-Governmental Organizations PART V: Change and Tribulation 12. Demographic Impact on Global Health Care 13. The Effect of Climate Change on Global Health Care 14. Global Infectious Diseases 15. Time of Geopolitical Changes and Polarization PART VI: Navigating the World’s Health Care Crisis 16. Ageing Population and Pension Systems 17. Health Care Access Crisis 18. Prevention, International Economic Development, Life-style Changes and New Strategies 19. The Future of Science, Medicine, the Pharmaceutical Industry, and Global Health Care
PART I: THE GLOBAL HEALTH CARE CRISIS
1. The World's Health Care Crisis: The United States' Leadership
2. The Health Care Crisis in Other Parts of the World
PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS
3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000
4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead
5. Understanding Research and Development and Marketing in a Biopharmaceutical Company
6. The Pharmaceutical Regulators
PART III: THE COMPLEXITY OF INNOVATION
7. The Academia-Industry Relationship
8. Translating Academic Innovation into Health Care Products
9. The Biotechnology World and Its Challenges
10. Causes of the Pharmaceutical Crisis
PART IV: MORALITY AND DUTY ON A LONELY PLANET
11. Wealth versus Poverty
12. Social Responsibility, Governmental Role, and Nongovernmental Organizations
PART I: The World’s Health Care Crisis 1. Introduction: Health Care and Health Care Crisis 2. The Health Care Crisis in the Industrialized World 3. Health Care in the Developing World and Emergent Economies PART II: The Biopharmaceutical Industry and Its Challenges 4. The Pharmaceutical Industry Globally 5. Understanding Research and Development and Marketing in a Biopharmaceutical Company 6. The Pharmaceutical Regulators and the Process of Drug Approval PART III: Life Sciences and Pharmaceutical Innovation 7. The Academia-Industry Relationship 8. Innovation at the Pharmaceutical and Biotechnology Industries 9. Global Investments in Life Sciences and Pharmaceutical Innovation PART IV: A World of Inequalities 10. Global health care disparities 11. Social Responsibility, Governmental Role, and Non-Governmental Organizations PART V: Change and Tribulation 12. Demographic Impact on Global Health Care 13. The Effect of Climate Change on Global Health Care 14. Global Infectious Diseases 15. Time of Geopolitical Changes and Polarization PART VI: Navigating the World’s Health Care Crisis 16. Ageing Population and Pension Systems 17. Health Care Access Crisis 18. Prevention, International Economic Development, Life-style Changes and New Strategies 19. The Future of Science, Medicine, the Pharmaceutical Industry, and Global Health Care
PART I: THE GLOBAL HEALTH CARE CRISIS
1. The World's Health Care Crisis: The United States' Leadership
2. The Health Care Crisis in Other Parts of the World
PART II: UNDERSTANDING THE BIOPHARMACEUTICAL BUSINESS
3. Brief Commercial History of the Biopharmaceutical Industry up to the Year 2000
4. The Biopharmaceutical Industry in the Twenty-first Century: Titanic Challenges Ahead
5. Understanding Research and Development and Marketing in a Biopharmaceutical Company
6. The Pharmaceutical Regulators
PART III: THE COMPLEXITY OF INNOVATION
7. The Academia-Industry Relationship
8. Translating Academic Innovation into Health Care Products
9. The Biotechnology World and Its Challenges
10. Causes of the Pharmaceutical Crisis
PART IV: MORALITY AND DUTY ON A LONELY PLANET
11. Wealth versus Poverty
12. Social Responsibility, Governmental Role, and Nongovernmental Organizations
PART V: REINVENTING RESEARCH AND DEVELOPMENT
13. Time for Reorganization
Rezensionen
"This book is an excellent summary of the health-care crisis facing the world today, comparing health care in wealthy, industrial countries to that in poor, underdeveloped countries. Sánchez-Serrano, a Panamian health-care adviser/consultant, covers the history of health care, including pharmaceutically driven treatments; challenges with new drug discoveries; unmet medical needs; and profits. The author also emphasizes the high cost of research and development for new drugs. He explores the issues related to government-supplemented research and summarizes the interaction of government-sponsored basic research, academic (pure) science research, venture capital investors, and industry.. The author provides many specific examples of successes and failures of past/present systems and discusses the evolution of pharmaceutical company philosophies in the past 150 years and future challenges. This book is fact based and nonpartisan. The only areas not explored are the modern diagnostics industry, the phenomenal advances in medical devices, and the cost of modern physician care (and the cost of physicians' education). Summing Up: Highly Recommended" --Choice
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826